U.S. Consumer Finance Stock News

Zimmer Biomet Holdings stock has had a difficult run over the past few years, yet the current valuation checks still lean toward the shares being cheap rather than expensive. The question for you is whether a weak long term share price record is masking an opportunity or simply reflecting the underlying business reality. Over the past 5 years, Zimmer Biomet Holdings has declined about 31.4%, which suggests investors have been cautious on the stock for a sustained period. Recent leadership...

1-800-FLOWERS.COM stock barely budged on the results, slipping less than 1% and leaving the share price near US$3 after a tough year where the chart has steadily ground lower. The market shrugged; the income statement did not. Quarterly revenue came in around US$293 million while the business posted another sizeable net loss, keeping the trailing twelve month earnings in the red. For short term traders, it looks like more of the same. Long term holders are staring at a different puzzle, with...

TransDigm Group stock has pulled back in recent months, yet the current share price still sits well above where it traded five years ago. A Discounted Cash Flow (DCF) intrinsic value estimate points to a material gap against the market price. With broader valuation checks sending a mixed signal rather than a clear cheap or expensive label, investors are left weighing a rich long term share performance against what the cash flow math suggests today. Over the past 5 years, TransDigm Group has...

Nike (NYSE:NKE) launched a $NKE stock token on the Solana blockchain through Sunrise, opening onchain access to its equity. The tokenized format allows crypto-native investors to trade exposure to Nike shares through Solana-based decentralized finance platforms. Sunrise acts as the onchain venue for $NKE token activity, connecting traditional equity exposure with Solana wallets and trading tools. Nike's move to issue a $NKE stock token on Solana through Sunrise fits into a wider shift toward...

BETA Technologies (BETA) is back in focus after helping launch America’s Consortium for Electric Skyways, a Texas-focused eVTOL charging effort tied to the White House’s integration pilot program, along with a fresh appearance at Jefferies’ Global Industrials Conference. Investors have reacted quickly to the ACES announcement and conference exposure, with BETA Technologies’ share price rising 6.44% on a 1 day basis to US$21.17, even though the 30 day share price return is down 10.98% and the...

Lovesac stock eased 2.5% to US$13.91 into Friday’s close, which looks tame given how emotionally charged furniture earnings can get. The headline is simple. The company printed a profitable Q2 on paper, with US$0.51 in earnings per share and US$7.4m of net income, but that picture leans heavily on a one time US$21m tariff refund. When that refund is excluded, the quarter tilts back toward an adjusted EBITDA loss. Traders appear conflicted. The mild price dip signals fatigue, while the...

Skyward Specialty Insurance Group (NasdaqGS:SKWD) reports that the integration of Apollo is creating a new fee-based earnings stream. Management describes the Apollo unit as materially additive to overall earnings, shifting part of the business toward fee-driven revenue. The integration is expected to change Skyward Specialty Insurance Group's revenue mix, with a larger share tied to recurring fee income. This new Apollo fee-based earnings stream is an important shift to weigh against the...

IDEAYA Biosciences (NasdaqGS: IDYA) and Servier have dosed the first patient in the OptimUM-11 global Phase 3 trial. OptimUM-11 is evaluating darovasertib plus crizotinib as adjuvant therapy for primary uveal melanoma patients at high risk of metastasis. The study is described as the first global registrational trial of this drug combination in the adjuvant setting for primary uveal melanoma. The launch of the OptimUM-11 Phase 3 darovasertib and crizotinib adjuvant trial is a key development...

FactSet Research Systems (FDS) recently revised its debt structure through an amendment to its existing credit agreement, extending key maturities and expanding revolving commitments to support future funding flexibility. Recent trading has been rough for FactSet Research Systems, with the share price down 14% over the past week and 6.6% over the last month, even though the 90-day share price return is still up 7.7% and the 1-year total shareholder return is lower by 26.9%. This points to...

THOR Industries announced a broad reshuffle of its North American RV leadership, with Ken Walters now heading North American RV operations, new presidents installed at Jayco and Keystone, and fresh appointments in marketing and finance to support the updated operating model. The creation of a dedicated North American RV leadership layer, including a group CFO and CMO, signals a push for tighter coordination across brands, sharper cost control, and more unified marketing in a highly...

Melco Resorts & Entertainment (NasdaqGS:MLCO) has drawn attention after recent trading left the share price at $5.05. Investors are weighing this casino operator’s global footprint against a series of weak recent return figures. Recent trading tells a mixed story for Melco Resorts & Entertainment. The 1-day share price return of 0.8% contrasts with a 30-day share price return down 8.5% and a 1-year total shareholder return down 47.4%. This points to fading momentum as investors reassess both...

Global Ship Lease (GSL) just declared a cash dividend of $0.546875 per depositary share on its 8.75% Series B preferred stock for the July to September quarter, payable to record holders on September 24. Against this preferred dividend announcement, Global Ship Lease’s common stock is trading at US$45.82, with a 1-month share price return of 11.11% and a year-to-date share price return of 31.21%. The 1-year total shareholder return of 53.07% and very large 3-year total shareholder return of...

Hinge Health (HNGE) drew fresh attention after its recent close at US$88.59, prompting investors to reassess a business built around AI-assisted musculoskeletal care and steady revenue and net income expansion. The pattern around Hinge Health over the past year is one of sharp share price momentum, with a 90 day share price return of 35.58% and a year to date share price gain of 94.45%, even though the 1 year total shareholder return is 53.72%. See how Hinge Health fits into the broader...

Gap (GAP) has drawn fresh attention after recent trading left the shares around $21.51, with performance mixed between the past month and past 3 months. That split sets up a valuation check. Recent trading in Gap has been choppy, with a 1-day share price return of 2.87% and a 30-day share price return of 6.22%. However, the year-to-date share price return is down 14.61%, while the 3-year total shareholder return of 111.13% signals earlier momentum that has cooled. This is why the current...

PepsiCo (PEP) just locked in a fresh fountain foothold. The Great Greek Mediterranean Grill named the company its official soft drink provider, with the partnership rolling out nationwide through 2026. For investors, this new PepsiCo pouring deal lands while the share price sits at US$136.27 and has drifted lower in recent months, with the 90 day share price return down 5.55% and the 3 year total shareholder return down 15.56%, signaling momentum that has been fading rather than building over...

Citigroup (NYSE:C) plans to launch blockchain-based tokenized deposit remittance services for Japanese corporate clients under local regulation. The offering will use a permissioned blockchain so businesses can move funds across jurisdictions within a regulated digital deposit framework. Japan's rules allow yield-bearing tokenized deposits, which this product is expected to incorporate for eligible corporate users. Citigroup's tokenized deposit rollout in Japan only captures part of the...

MARA Holdings (MARA) is back in focus after its share price weakened alongside a drop in Bitcoin below a key level and broader market softness, just as investors look toward the next earnings update. For context, MARA Holdings has seen a sharp 24.17% 1 month share price return and a 5.84% 7 day share price move, yet the 1 year total shareholder return is still down 26.61%. This suggests recent momentum is building, but longer term holders remain under water. Short term trading has been...

Cushman & Wakefield reported that U.S. legal sector tenants leased a record 7.3 million square feet in Q2 2026, with first half activity reaching about 12.2 million square feet and driven by larger deals and law firm expansions. The surge in legal office leasing points to robust demand for larger, higher quality workspaces, which feeds directly into Cushman & Wakefield's fee pool and underlines how sector specific strength can support broader office leasing recovery. We will look at how...

Charles Schwab has delivered a powerful 3 year share-price run, yet its current valuation checks send a mixed signal, with the Excess Returns intrinsic value estimate pointing to some undervaluation while market multiples look closer to fair. The stock is up about 92% over three years, which puts fresh pressure on buyers to judge whether that past strength already reflects the business outlook. Schwab's move to raise minimums on certain tax-aware long short accounts can support perceived...

The RH story has been sold as a high-end design platform with outsized earnings potential, yet the stock barely moved after this report, closing up just 0.04% and still down sharply over the past month. That muted reaction sits awkwardly next to a quarter where revenue reached US$922.2m and basic earnings per share came in at US$3.18, a sharp swing from the loss earlier this year. For you as a shareholder or would-be buyer, the real headline is simple. Profitability snapped back while the...

Guardant Health (NasdaqGS:GH) has been named one of America's Most Innovative Businesses by Business Insider. The company received five-star recognition in the ranking for its leadership in precision oncology. Business Insider's list highlights factors such as research spending, peer perception, and patent activity across US corporations. The five-star precision oncology recognition is important, but investors should weigh it alongside other signals for Guardant Health. Check out 2 warning...

Merck stock has delivered strong gains over the past few years, yet the valuation signals are split, as a Discounted Cash Flow (DCF) view points to a sizable gap to intrinsic value while market based multiples suggest the shares already carry a premium. That mix leaves investors weighing a low overall value score against an intrinsic value estimate that screens the stock as materially undervalued. Over the past 5 years, Merck has returned 132.6%, which puts recent pricing on a very different...

Universal Display (OLED) is back in focus after an extended slide that has left the stock trailing wider market returns, as investors reassess muted revenue and earnings trends against other options. At a share price of US$83.56, Universal Display has seen a brief rebound with a 1-day share price return of 2.96%. However, the 30-day share price return is down 9.18% and the 1-year total shareholder return has declined 37.69%, pointing to fading momentum as investors question the stock’s growth...

The market loved Tsakos Energy Navigation on Friday. The stock jumped 7.1% to US$47.90, and that enthusiasm is riding almost entirely on one thing: profit power. Q2 earnings landed with Basic EPS of US$4.40 and net income of US$131.9m on revenue of US$298.4m. For a tanker owner, that profit per share and cash generation story is what traders are reacting to, while longer term questions on balance sheet use and future tanker rates sit quietly in the background for now. Is Tsakos Energy...